Discovering and bringing a new drug to market typically takes 14 years and costs approximately $ 2 billion USD. Today, the competitive landscape throughout the drug development process requires ...
SHANGHAI, Dec. 29, 2025 /PRNewswire/ -- Drug Pharmacokinetics and Pharmacodynamics (PKPD) has become increasingly critical as drug discovery modalities continue to expand across a broader and more ...
QPS is reaching out to Hepregen to boost its early stage development offerings, licensing the company's "liver-in-a-dish" technology for drug metabolism and pharmacokinetic testing. Under the deal, ...
“Marketresearch.biz reports that the Global Drug Metabolism And Pharmacokinetics (Dmpk) Market was valued at USD 1.2 billion in 2023. It is expected to reach USD 2.6 billion by 2033, with a CAGR of ...
Nottingham, UK – 24 September 2020 – Life Science Newswire – Sygnature Discovery, a world-leading integrated discovery and pre-clinical solutions provider, has significantly expanded its DMPK ...
WALTHAM, Mass., May 16, 2022 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing innovative life-transforming therapeutics for people living with ...
Proteolysis-targeting chimeras (PROTACs) are bifunctional molecules that leverage the body’s internal protein disposal system to target and degrade disease-causing proteins. Emerged in 2001, PROTACs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results